Open Academia: Journal of Scholarly Research

New Biochemical Parameters That Can Be Used to Diagnose Patients with G6PD Deficiency

Dr. Saad M. Saeed

Directorate of Education, Diyala

Mohammed R. Tuama

Directorate of Education, Diyala

Prof. Dr. Nazar A. Naji

Almashreq University College of Dentistry

Keywords: deficiency, Biochemical Parameters, Serum Biomarkers

---

Abstract

Glucose-6-phosphate dehydrogenase (G6PD) deficiency is an inherited enzyme deficiency that affects millions of people worldwide, particularly in certain regions with high prevalence. Although diagnosis of G6PD deficiency traditionally relies on biochemical assays such as the fluorescent spot test and enzymatic activity tests, there is growing interest in exploring novel biochemical parameters that can aid in the diagnosis of this condition. In this research we will take (90) sample from serum of glucose-6-phosphate dehydrogenase deficiency patients and control and we will determine level of the glucose-6-phosphate dehydrogenase, albumin, total protein, and other biochemical parameters such as liver function; Alanine transaminase (ALT), Aspartate aminotransferase (AST), Alkaline phosphatase (ALP), Bilirubin and compared with new biochemical parameters such as myo-inositol oxidase, hepcidin and haptoglobin. At the end of this research. The results showed that there was a significant decrease (P

<0.05) in the serum levels of G6PD in patient’s group when compared with control group. Also, there were a significant increase (P><0.05) in the serum levels of albumin, total protein, ALP, ALT, AST and total bilirubin in patients with (G6PD) deficiency groups when compared with control group. In addition, this research reveals strong positive correlation between some biochemical parameters that we were studied such as total protein with TSB, total protein with albumin, ALT with TSB and Albumin with TSB>

---

References

Ryan, K., & Tekwani, B. L. (2021). Current investigations on clinical pharmacology and

therapeutics of glucose-6-phosphate dehydrogenase deficiency. Pharmacology &

therapeutics, 222, 107788.

Swastika, M., Harahap, A. R., Panggalo, L. V., Jusman, S. W. A., & Satyagraha, A. W.

(2020). Determining a critical threshold for G6PD activity below which red blood cell

response to oxidative stress is poor. Malaria Journal, 19, 1-10.

Ghani, M. U., Yang, Z., Feng, T., Chen, J., Khosravi, Z., Wu, Q., & Cui, H. (2024).

Comprehensive review on glucose 6 phosphate dehydrogenase: A critical

immunometabolic and redox switch in insects. International Journal of Biological

Macromolecules, 132867.

Z. Liu et al. (2020). “Chinese newborn screening for the incidence of G6PD deficiency

and variant of G6PD gene from 2013 to 2017,” Hum. Mutat., vol. 41, no. 1, pp. 212–

, doi: 10.1002/humu.23911.

F. Rajas, A. Gautier-Stein, and G. Mithieux. (2019). “Glucose-6 phosphate, A central

hub for liver carbohydrate metabolism,” Metabolites, vol. 9, no. 12, Dec. doi:

3390/metabo9120282.

J. Zou et al. (2023). “Zuogui-Jiangtang-Qinggan-Fang alleviates high-fat diet-induced

type 2 diabetes mellitus with non-alcoholic fatty liver disease by modulating gut

microbiome-metabolites-short chain fatty acid composition,” Biomed. Pharmacother.,

vol. 157, no. November 2022, p. 114002, doi: 10.1016/j.biopha.2022.114002.

Y. Shu, F. Hassan, M. C. Ostrowski, and K. D. Mehta. (2021). “Role of hepatic PKCβ

in nutritional regulation of hepatic glycogen synthesis,” JCI Insight, vol. 6, no. 19, pp.

–15, doi: 10.1172/jci.insight.149023.

B. Cadet, D. Meshoyrer, and Z. Kim. (2021) “Atypical hemolytic uremic syndrome:

when pregnancy leads to lifelong dialysis: a case report and literature review,”

Cardiovasc. Endocrinol. Metab., vol. 10, no. 4, pp. 225–230, doi:

1097/xce.0000000000000247.

T. B. Bennike et al.( 2020). “Preparing for Life: Plasma Proteome Changes and Immune

System Development During the First Week of Human Life,” Front. Immunol., vol. 11,

no. October, pp. 1–18, doi: 10.3389/fimmu.2020.578505.

Wu, H., Oliveira, G., & Lila, M. A. (2023). Protein‐binding approaches for improving

bioaccessibility and bioavailability of anthocyanins. Comprehensive Reviews in Food Science and Food Safety, 22(1), 333-354.

M. Orsaria, A. P. Londero, S. Marzinotto, C. DI Loreto, Di. Marchesoni, and L.

Mariuzzi. (2017). “Placental type alkaline phosphatase tissue expression in ovarian

serous carcinoma,” Cancer Biomarkers, vol. 17, no. 4, pp. 479–486, doi: 10.3233/CBM160665.

Montt-Guevara, M. M., Finiguerra, M., Marzi, I., Fidecicchi, T., Ferrari, A., Genazzani,

A. D., & Simoncini, T. (2021). D-Chiro-Inositol Regulates Insulin Signaling in Human

Adipocytes. Frontiers in Endocrinology, 12, 660815.

Fallahi, P., Ferrari, S. M., Elia, G., Ragusa, F., Paparo, S. R., Caruso, C., ... & Antonelli,

A. (2018). Myo-inositol in autoimmune thyroiditis, and hypothyroidism. Reviews in

endocrine and metabolic disorders, 19, 349-354.

Munoz, C. J., Pires, I. S., Jani, V., Gopal, S., Palmer, A. F., & Cabrales, P. (2022).

Apohemoglobin-haptoglobin complex alleviates iron toxicity in mice with βthalassemia via scavenging of cell-free hemoglobin and heme. Biomedicine &

Pharmacotherapy, 156, 113911.

Lee, N., Makani, J., Tluway, F., Makubi, A., Armitage, A. E., Pasricha, S. R., ... & Cox,

S. E. (2018). Decreased Hepcidin levels are associated with low steady-state hemoglobin

in children with sickle cell disease in Tanzania. EBioMedicine, 34, 158-164.

S. S. Saleh. (2019). “Study the effectiveness of (G-6-phd) enzyme and the level of fats

in peoples with leukemia,” Int. J. Pharm. Qual. Assur., vol. 10, no. 3, pp. 142–146, doi:

25258/IJPQA.10.3.6.

Gao, P., Xu, B., Song, P., Zhu, X., Yuan, S., Kanwar, Y. S., & Sun, L. (2018). The

kidney specific protein myo-inositol oxygenase, a potential biomarker for diabetic

nephropathy. Kidney and Blood Pressure Research, 43(6), 1772-1785.

Dawood, D. S., & Hussein, R. J. (2021). Estimation of Apolipoprotein A1, Haptoglobin

and Alpha 2macroglobulin with some Biochemical Metabolic Markers in Nonalcoholic

Fatty Liver Disease Iraqi Patients. Journal of Techniques, 3(1), 24-30.

Roy, J. E., Kalaiselvi, V. S., & Shanthi, B. (2021). Study on serum hepcidin level in

chronic kidney disease. Annals of the Romanian Society for Cell Biology, 2715-2727.

Ghazala, M. M., Abdellateif, S. S., Taher, M. M. S., Abdelmohsen, E. A., Bakheet, O.

H., & Assem, A. A. A. (2021). Serum hepcidin and growth differentiation factor 15 in

patients with β-thalassemia and its relation to blood transfusion. Al-Azhar International

Medical Journal, 2(3), 43-48.

J. Xu, Y. Yang, A. Jiang, and H. Zhu. (2020). “Critical Reviews in Analytical Chemistry

Detection Methods and Research Progress of Human Serum Albumin Detection

Methods and Research Progress of Human Serum Albumin,” Crit. Rev. Anal. Chem.,

vol. 0, no. 0, pp. 1–21, doi: 10.1080/10408347.2020.1789835.

B. T. Doumas. (1975). “Standards for total serum protein assays: a collaborative study,”

Clin. Chem., vol. 21, no. 8, pp. 1159–1166, doi: 10.1093/clinchem/21.8.1159.

Ndeh, F. J., Ojong, E. W., Akpan, U. O., & Ekeagba, I. I. (2022). Serum Amino

Transaminases Activities and De Ritis Ratio amongst Apparently Healthy Secretors and

Non-Secretors of ABH Substances Dwelling in Uyo Urban, Akwa Ibom State, Nigeria.

Asian Journal of Research and Reports in Hepatology, 4(1), 1-20.

Rami, L., Roura, M., & Canalias, F. (2012). Evaluation of commutability of several

materials for harmonization alkaline phosphatase catalytic concentration measurements.

Clinica Chimica Acta, 413(15-16), 1249-1254.